Patient’s Journey in LHSC’s Stem Cell Transplant Program

Becky Jones, a traveler who began feeling tired and weak during a trip in 2022, discovered she had leukemia after a blood test revealed the diagnosis. The London Regional Cancer Program (LRCP) at London Health Sciences Centre (LHSC) contacted Jones to discuss treatment options. Stem cell transplant was considered due to the specific type of mutation. LHSC, one of six hospitals in Ontario that offer stem cell transplantation services, supports both autologous and allogeneic transplants. Jones received an allogeneic related donor transplant, which involved using healthy stem cells from a relative to replace bone marrow that was not producing enough healthy blood cells.

Stem cell transplantation is often the primary treatment for blood cancer or blood diseases, providing lasting remission and a new immune system for patients. Jones underwent a series of chemotherapy treatments while searching for a suitable stem cell donor. Both her twin sister and brother were matches, but it was determined that Dale, her brother, had the highest chances for a successful transplant and recovery. The donation process took several hours, and Jones received the stem cell transplant, supporting her through the recovery process. Following the transplant, her health improved significantly, and she only required regular check-up appointments. Jones expressed gratitude for her brother’s selflessness and the exceptional care she received from the specialized team at LHSC, which was conveniently close to her home.

Help improve our content system

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

Share this story:

Transplant News
Transplant News

Transplant News brings you the news and content that matters to the transplant community. From patient stories, to the latest in transplant innovation, Transplant News is your window into the world of transplantation.